However, given the rarity of the disease, our case series, albeit preliminary, represents a significant sample sufficient to speculate on the role of TEX41 as a prognostic biomarker of B-ALL as well as a putative regulator of the cell cycle by influencing the p53 expression. The gene discussed is TP53; the disease is acute lymphoblastic leukemia.